ReviewPharmaceutics2026

Targeting SARS-CoV-2 Non-Structural Proteins: A Blueprint for Next-Generation Small-Molecule Coronavirus Antivirals.

Exequiel O J Porta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.